Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Biochimica Et Biophysica Acta. Reviews on Cancer|November 4, 2024
Current understanding of brachyury in chordomaTianshun Ma, Jiwei Bai, Yazhuo ZhangJournal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 26, 2013
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomasJiwei Bai, Songbai Gui, Yazhuo ZhangNeural Regeneration Research|March 26, 2015
Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cellsJiwei Bai, Yan Wang, Chuzhong Li, et al.Frontiers in Oncology|May 17, 2021
High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in GliomaYujia Xiong, Mingxuan Li, Jiwei Bai, et al.Journal of Cancer|January 6, 2023
Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B PathwayQian Liu, Yutao Shen, Yujia Xiong, et al.Oncology Letters|February 22, 2013
Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomasRunchun Lu, Hua Gao, Hongyun Wang, et al.Frontiers in Oncology|September 26, 2022
PALB2 as a factor to predict the prognosis of patients with skull base chordomaYujia Xiong, Mingxuan Li, Yutao Shen, et al.Frontiers in Oncology|January 2, 2023
Development and validation of a preoperative MRI-based radiomics nomogram to predict progression-free survival in patients with clival chordomasYixuan Zhai, Jiwei Bai, Yake Xue, et al.Molecular Medicine Reports|March 6, 2017
Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approachChunhui Liu, Youtu Wu, Shengyuan Yu, et al.Journal of Neurosurgery|December 28, 2019
A nomogram to predict the progression-free survival of clival chordomaYixuan Zhai, Jiwei Bai, Mingxuan Li, et al.Pageof 7